US Capitol Capsule: In 'transformative' 2013, reimbursement tussles expected for biopharma
This article was originally published in Scrip
Executive Summary
The evolution that's been taking place over the past several years in heath care is now in full-throttle mode, with 2013 expected to be a truly transformative year – creating a market shift for industry, according to PricewaterhouseCoopers (PwC), a US-based auditing, consulting and tax service firm.